Paper
14 June 2004 NIR optical probes targeting glucose transporters
Hui Li, Juan Chen, Min Zhang, Zhihong Zhang, David Benaron, Britton Chance, Jerry D. Glickson, Gang Zheng
Author Affiliations +
Abstract
A current limitation of NIR imaging is the lack of sufficient tumor-to-tissue contrast due to the nonspecific nature of delivering the dye to the tumor. Utilizing one of the most important cancer signatures, the overexpression of GLUTs, we have developed a series of 2-deoxyglucose conjugated NIR dyes (NIR- 2DG) to enhance tumor selectivity. This uptake mechanism is first confirmed in vitro by confocal microscopy and flow cytometry studies with various cancer cells. Following intravenously administration to animals, NIR-2DGs are selectively accumulated in the tumor compared to the surrounding normal tissue as observed by ex vivo and in vivo fluorescence imaging techniques.
© (2004) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Hui Li, Juan Chen, Min Zhang, Zhihong Zhang, David Benaron, Britton Chance, Jerry D. Glickson, and Gang Zheng "NIR optical probes targeting glucose transporters", Proc. SPIE 5329, Genetically Engineered and Optical Probes for Biomedical Applications II, (14 June 2004); https://doi.org/10.1117/12.533148
Lens.org Logo
CITATIONS
Cited by 3 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Near infrared

Cancer

In vivo imaging

Confocal microscopy

Glucose

Luminescence

Back to Top